Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Panita who wrote (19967)	12/1/1998 3:04:00 PM
From: HiSpeed	Read Replies (1) \| Respond to of 119973

BEAM ,- why the move today - what's the news on BEAM?

To: Panita who wrote (19967)	12/1/1998 3:04:00 PM
From: EyeDrMike	Read Replies (2) \| Respond to of 119973

TAVA news TAVA's Medical Product Licencee Shows Growing Backlog ENGLEWOOD, Colo., Dec. 1 /PRNewswire/ -- TAVA Technologies (Nasdaq: TAVA) a leading provider of automation and information technology solutions to industry, announced today that the company expects to receive initial license revenues from its licensee, BioMed Y2K, a subsidiary of Colorado MEDtech, Inc. (Nasdaq: CMED), in the quarter ending December 31, 1998. Earlier this year, TAVA licensed its PlantY2kOne product technology to BioMed Y2K. BioMed Y2K used that technology to develop a suite of products designed specifically to address year 2000 compliance issues in embedded technology found in biomedical devices used in hospitals, clinics, and extended care facilities.